This funding supports studies that address key methodological gaps in patient-centered comparative clinical effectiveness research. Priority areas include patient-centered measurement, use of real-world data in multi-site studies, artificial intelligence and machine learning applications, and improvements to study design. Projects may receive up to $750,000 in direct costs for up to three years and require meaningful patient and partner engagement.
Eligibility criteria are not specified in the announcement.
